Pila Pharma AB (publ) (STO:PILA)
Sweden
· Delayed Price · Currency is SEK 1.136
-0.046 (-3.89%)
Mar 9, 2026, 4:41 PM CET
Pila Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 15.9 | 4.89 | 5.95 | 7.24 | 28.21 | Upgrade
|
| Cash & Short-Term Investments | 15.9 | 4.89 | 5.95 | 7.24 | 28.21 | Upgrade
|
| Cash Growth | 224.89% | -17.82% | -17.79% | -74.33% | 1379.11% | Upgrade
|
| Accounts Receivable | - | - | 0.05 | - | - | Upgrade
|
| Other Receivables | 0.15 | 0.07 | 0.23 | 0.2 | 0.15 | Upgrade
|
| Receivables | 0.15 | 0.07 | 0.28 | 0.2 | 0.15 | Upgrade
|
| Prepaid Expenses | 0.11 | 0.05 | 0.01 | 0.14 | 0.14 | Upgrade
|
| Other Current Assets | 0 | - | - | - | - | Upgrade
|
| Total Current Assets | 16.15 | 5.01 | 6.24 | 7.59 | 28.5 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | 0.02 | Upgrade
|
| Long-Term Investments | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Other Intangible Assets | - | 1.08 | 2.15 | 3.23 | 3.23 | Upgrade
|
| Other Long-Term Assets | - | 0.07 | - | - | - | Upgrade
|
| Total Assets | 16.22 | 6.22 | 8.46 | 10.89 | 31.81 | Upgrade
|
| Accounts Payable | 0.23 | 0.44 | 0.4 | 0.35 | 0.35 | Upgrade
|
| Accrued Expenses | 0.73 | 0.48 | 0.13 | 0.69 | 0.59 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.13 | 0.13 | 0.04 | Upgrade
|
| Other Current Liabilities | 0.47 | 0.04 | 1.14 | 0.19 | 0.53 | Upgrade
|
| Total Current Liabilities | 1.43 | 0.96 | 1.79 | 1.36 | 1.51 | Upgrade
|
| Total Liabilities | 1.43 | 0.96 | 1.79 | 1.36 | 1.51 | Upgrade
|
| Common Stock | 1.8 | 1.16 | 1.02 | 0.79 | 0.69 | Upgrade
|
| Additional Paid-In Capital | 123.33 | 97.59 | 87.89 | 81.06 | 75.14 | Upgrade
|
| Retained Earnings | -110.35 | -93.48 | -82.24 | -72.31 | -45.54 | Upgrade
|
| Shareholders' Equity | 14.78 | 5.26 | 6.66 | 9.53 | 30.3 | Upgrade
|
| Total Liabilities & Equity | 16.22 | 6.22 | 8.46 | 10.89 | 31.81 | Upgrade
|
| Net Cash (Debt) | 15.9 | 4.89 | 5.95 | 7.24 | 28.21 | Upgrade
|
| Net Cash Growth | 224.89% | -17.82% | -17.79% | -74.33% | 1904.68% | Upgrade
|
| Net Cash Per Share | 0.46 | 0.19 | 0.28 | 0.42 | 2.16 | Upgrade
|
| Filing Date Shares Outstanding | 42.08 | 27.13 | 23.79 | 18.41 | 16.1 | Upgrade
|
| Total Common Shares Outstanding | 42.08 | 27.13 | 23.79 | 18.41 | 16.1 | Upgrade
|
| Working Capital | 14.72 | 4.05 | 4.44 | 6.23 | 26.98 | Upgrade
|
| Book Value Per Share | 0.35 | 0.19 | 0.28 | 0.52 | 1.88 | Upgrade
|
| Tangible Book Value | 14.78 | 4.18 | 4.51 | 6.3 | 27.06 | Upgrade
|
| Tangible Book Value Per Share | 0.35 | 0.15 | 0.19 | 0.34 | 1.68 | Upgrade
|
| Machinery | - | - | - | - | 0.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.